Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study

被引：0
|
作者：
Clowse, Megan E. B. [1 ]
Forger, Frauke [2 ]
Hwang, Caroline [3 ]
Thorp, John [4 ]
Dolhain, Radbound J. E. M. [5 ]
van Tubergen, Astrid [6 ]
Teil, Marie [7 ]
Toublanc, Nathalie [7 ]
Hale, Thomas [7 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC 27706 USA
[2] Univ Hosp Bern, Inselspital, Bern, Switzerland
[3] Keck Hosp USC, Los Angeles, CA USA
[4] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[5] Univ Med Ctr Rotterdam, Rotterdam, Netherlands
[6] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[7] Texas Tech Univ, Sch Med, Lubbock, TX 79409 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
4821
引用
收藏
页码：AB127 / AB127
页数：1
相关论文
共 50 条
  • [21] EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY
    Saraux, A.
    Flipo, R. M.
    Fagnani, F.
    Massol, J.
    Combe, B.
    Huot-Marchand, P.
    Joubert, J. M.
    Dunkel, J.
    Cukierman, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 786 - 787
  • [22] Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study
    Sandborn, William J.
    Schreiber, Stefan
    Hanauer, Stephen B.
    Colombel, Jean-Frederic
    Bloomfield, Ralph
    Lichtenstein, Gary R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (08) : 696 - 702
  • [23] RESULTS OF IVF FROM A PROSPECTIVE MULTICENTER STUDY
    HAAN, G
    BERNARDUS, RE
    HOLLANDERS, JMG
    LEERENTVELD, RA
    PRAK, FM
    NAAKTGEBOREN, N
    HUMAN REPRODUCTION, 1991, 6 (06) : 805 - 810
  • [24] Effect of Patient Age on Outcomes in Breast Reconstruction: Results from a Multicenter Prospective Study
    Santosa, Katherine B.
    Qi, Ji
    Kim, Hyungjin M.
    Hamill, Jennifer B.
    Pusic, Andrea L.
    Wilkins, Edwin G.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (06) : 745 - 754
  • [25] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Kumar, Namita
    Naz, Sophia
    Quinn, Mark
    Ryan, John
    Kumke, Thomas
    Sheeran, Tom
    ADVANCES IN THERAPY, 2018, 35 (09) : 1426 - 1437
  • [26] CERTOLIZUMAB PEGOL DID NOT RESULT IN A DECREASE IN SEMEN QUALITY IN HEALTHY VOLUNTEERS: RESULTS FROM A PHASE 1 STUDY
    d'Hauterive, S. Perrier
    Kesseler, S.
    Ruggeri, P.
    Timmermans, M.
    Gaspard, O.
    Kumke, T.
    Parker, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 365 - 366
  • [27] Certolizumab Pegol for the Treatment of Psoriasis Arthritis: 4-Year Results from the RAPID-PSA Study
    Hoepken, B.
    Mease, P. J.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Gladman, D.
    Petersen, L.
    van der Heijde, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 140 - 141
  • [28] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Namita Kumar
    Sophia Naz
    Mark Quinn
    John Ryan
    Thomas Kumke
    Tom Sheeran
    Advances in Therapy, 2018, 35 : 1426 - 1437
  • [29] Transdermal buprenorphine in clinical practice: results from a multicenter, noninterventional postmarketing study in Slovenia
    Skvarc, Nevenka Krcevski
    PAIN MANAGEMENT, 2012, 2 (02) : 177 - 183
  • [30] Treatment strategies in male breast cancer: Results of a prospective multicenter study
    Eggemann, Holm
    Brucker, Cosima
    Schirrmeister, Susen
    Ringsdorf, Uta
    Augustin, Doris
    Schrauder, Michael
    Thill, Marc
    Flock, Felix
    Kraudelt, Susanne
    Gad, Gabriele
    Kleine-Tebbe, Anke
    Reinisch, Mattea
    Costa, Serban-Dan
    Ignatov, Atanas
    CANCER RESEARCH, 2020, 80 (04)
12345